ImmunityBio, Inc. (IBRX)
7.24
+0.07
(+0.98%)
USD |
NASDAQ |
Jun 09, 16:00
7.24
0.00 (0.00%)
After-Hours: 17:30
ImmunityBio Total Assets (Quarterly) : 646.64M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sana Biotechnology, Inc. | 373.59M |
| Erasca, Inc. | 461.23M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Denali Therapeutics, Inc. | 1.266B |
| Cogent Biosciences, Inc. | 903.01M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.516B |
| Shareholders Equity (Quarterly) | -870.01M |
| Debt to Equity Ratio | -1.293 |
| Current Ratio | 6.666 |
| Net Debt Paydown Yield | -0.83% |